Jefferies Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Q2 Bottoms Out; Q3 Rebound with Leuco
Tweet Send to a Friend
Jefferies maintains a 'Buy' on Sagent Pharmaceuticals (NASDAQ: SGNT) price target of $23.00.
Analyst, Corey Davis, said, "Sagent's execution ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Corey Davis, said, "Sagent's execution ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
